Study points to simpler lab model for feline coronavirus research

CURRENT BRIEF VERSION: Researchers at Murdoch University reported that they successfully propagated feline coronavirus from three clinically diagnosed feline infectious peritonitis, or FIP, cases in Vero cells, a widely used non-feline cell line. The study, published in Veterinary Record Open in February 2026, found consistent cytopathic effects, including cell rounding, shrinkage, detachment, monolayer clearing, and cell death, with RT-qPCR and sequencing supporting viral replication across passages. The authors say that matters because feline coronavirus, especially clinically relevant strains linked to FIP, has historically been difficult to grow in standard cell culture systems, which has slowed laboratory research. (pmc.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals, this is a research infrastructure story more than a clinical practice change. A workable in vitro model could make it easier to study viral behavior, compare strains, evaluate antiviral resistance, and build more practical screening systems for candidate drugs or vaccines. That said, the paper is based on just three cats from Perth, Western Australia, and the authors note important limits, including the lack of multiplex testing for co-infections and the fact that Vero cells are not ideal for studying feline-specific immune responses or pathogenesis. That immune question is increasingly important: recent UC Davis work found FIP-associated coronavirus in a broader range of immune cells than previously thought, including B and T lymphocytes, with evidence of active replication and possible persistence after antiviral treatment. Recent FIP guidance also underscores how much remains unsettled in the field, especially as clinicians navigate newer antiviral use and emerging strains such as the highly virulent Cyprus outbreak strain linked to FCoV-23, which has raised concern about cat-to-cat spread and cross-border movement of infected cats. (pmc.ncbi.nlm.nih.gov)

What to watch: Watch for follow-up studies that validate the model with more isolates, clarify whether these propagated viruses are predominantly type II strains, and test whether the platform is robust enough for antiviral screening or vaccine work. It will also be worth watching whether better culture systems help researchers study immune-cell tropism, viral persistence after treatment, and outbreak-associated strains in a more standardized way. (pmc.ncbi.nlm.nih.gov)